Page 129 - Read Online

Musumeci et al. J Transl Genet Genom 2020;4:221-37 I https://doi.org/10.20517/jtgg.2020.22 Page 233

Conflicts of interest
All authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2020.

REFERENCES
1. Schaefer AM, McFarland R, Blakely EL, He L, Whittaker RG, et al. Prevalence of mitochondrial DNA disease in adults. Ann Neurol
2008;63:35-9.
2. Schapira AHV. Mitochondrial disorders. Lancet 2012;379:1825-34.
3. DiMauro S, Schon EA, Carelli V, Hirano M. The clinical maze of mitochondrial neurology. Nat Rev Neurol 2013;9:429-44.
4. McFarland R, Taylor RW, Turnbull DM. A neurological perspective on mitochondrial disease. Lancet Neurol 2010;9:829-40.
5. Hanna MG, Bhatia KP. Movement disorders and mitochondrial dysfunction. Curr Opin Neurol 1997;10:351-6.
6. Tranchant C, Anheim M. Movement disorders in mitochondrial diseases. Rev Neurol 2016;172:524-9.
7. Ghaoui R, Sue CM. Movement disorders in mitochondrial disease. J Neurol 2018;265:1230-40.
8. Martikainen MH, Ng YS, Gorman GS, Alston CL, Blakely EL, et al. Clinical, genetic, and radiological features of extrapyramidal
movement disorders in mitochondrial disease. JAMA Neurol 2016;73:668-74.
9. Moustris A, Edwards MJ, Bhatia KP. Movement disorders and mitochondrial disease. Handb Clin Neurol 2011;100:173-92.
10. Flønes IH, Tzoulis C. Movement disorders in mitochondrial disease: a clinicopathological correlation. Curr Opin Neurol 2018;31:472-83.
11. Truong DD, Harding AE, Scaravilli F, Smith SJ, Morgan-Hughes JA, et al. Movement disorders in mitochondrial myopathies. A study of
nine cases with two autopsy studies. Mov Disord 1990;5:109-17.
12. Macaya A, Munell F, Burke RE, De Vivo DC. Disorders of movement in Leigh syndrome. Neuropediatrics 1993;24:60-7.
13. Papandreou A, Rahman S, Fratter C, Ng J, Meyer E, et al. Spectrum of movement disorders and neurotransmitter abnormalities in
paediatric POLG disease. J Inherit Metab Dis 2018;41:1275-83.
14. Schreglmann SR, Riederer F, Galovic M, Ganos C, Kägi G, et al. Movement disorders in genetically confirmed mitochondrial disease and
the putative role of the cerebellum. Mov Disord 2018;33:146-55.
15. Fahn S. Classification of movement disorders Mov Disord 2011;26:947-57.
16. LeDoux MS. The genetics of dystonias. Adv Genet 2012;79:35-85.
17. Marras C, Lang A, van de Warrenburg BP, Sue CM, Tabrizi SJ, et al. Nomenclature of genetic movement disorders: recommendations of
the international Parkinson and movement disorder society task force. Mov Disord 2016;31:436-57.
18. Chang X, Wu Y, Zhou J, Meng H, Zhang W, et al. A meta-analysis and systematic review of Leigh syndrome: clinical manifestations,
respiratory chain enzyme complex deficiency, and gene mutations. Medicine 2020;99:e18634.
19. Naess K, Freyer C, Bruhn H, Wibom R, Malm G, et al. mtDNA mutations are a common cause of severe disease phenotypes in children
with Leigh syndrome. Biochim Biophys Acta 2009;1787:484-90.
20. Sofou K, De Coo IF, Isohanni P, Ostergaard E, Naess K, et al. A multicenter study on Leigh syndrome: disease course and predictors of
survival. Orphanet J Rare Dis 2014;9:52.
21. Zhang Y, Yang YL, Sun F, Cai X, Qian N, et al. Clinical and molecular survey in 124 Chinese patients with Leigh or Leigh like syndrome.
J Inherit Metab Dis 2007;30:265.
22. Sofou K, de Coo IFM, Ostergaard E, Isohanni P, Naess K, et al. Phenotype-genotype correlations in Leigh syndrome: new insights from a
multicentre study of 96 patients. J Med Genet 2018;55:21-27.
23. Piekutowska-Abramczuk D, Popowska E, Pronicki M, Karczmarewicz E, Tylek-Lemanska D, et al. High prevalence of SURF1
c.845_846delct mutation in Polish Leigh patients. Eur J Paediatr Neurol 2009;13:146-53.
24. Tolomeo D, Rubegni A, Severino M, Pochiero F, Bruno C, et al. Clinical and neuroimaging features of the m.10197G>A mtDNA
mutation: new case reports and expansion of the phenotype variability. J Neurol Sci 2019;399:69-75.
25. Ugalde C, Triepels RH, Coenen MJ, van den Heuvel LP, Smeets R, et al. Impaired complex I assembly in a Leigh syndrome patient with
a novel missense mutation in the ND6 gene. Ann Neurol 2003,54:665-9.
26. Wang K, Takahashi Y, Gao ZL, Wang GX, Chen XW, et al. Mitochondrial ND3 as the novel causa tive gene for Leber hereditary optic
neuropathy and dystonia. Neurogenetics 2009;10:337-45.
27. Gropman A, Chen TJ, Perng CL, Krasnewich D, Chernoff E, et al. Variable clinical manifestation of homoplasmic G14459A
mitochondrial DNA mutation. Am J Med Genet A 2004;124A:377-82.
28. Rahman S, Thorburn D. Nuclear gene-encoded leigh syndrome overview. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH,